11.79
price down icon0.59%   -0.07
pre-market  Vorhandelsmarkt:  11.70   -0.09   -0.76%
loading

Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten

pulisher
04:07 AM

What machine learning models say about Neuphoria Therapeutics Inc.2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com

04:07 AM
pulisher
Sep 30, 2025

Will Neuphoria Therapeutics Inc. stock gain from government policiesQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Reversal indicators forming on Neuphoria Therapeutics Inc. stockJuly 2025 Technicals & Fast Moving Stock Watchlists - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What drives Neuphoria Therapeutics Inc stock priceFibonacci Retracement Levels & Low Entry Investment Growth - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Will Neuphoria Therapeutics Inc. stock maintain momentum in 20252025 Market WrapUp & Community Trade Idea Sharing - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Can Neuphoria Therapeutics Inc. stock weather global recessionTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Measuring Neuphoria Therapeutics Inc.’s beta against major indicesJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is Neuphoria Therapeutics Inc. stock cheap compared to fundamentalsPortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is Neuphoria Therapeutics Inc a good long term investmentPrice Momentum Alerts & Identify Breakout Stocks - earlytimes.in

Sep 30, 2025
pulisher
Sep 29, 2025

Neuphoria completes patient visits in phase 3 social anxiety trial By Investing.com - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Neuphoria completes patient visits in phase 3 social anxiety trial - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewswire Inc.

Sep 29, 2025
pulisher
Sep 29, 2025

Neuphoria Therapeutics Inc. SEC 10-K Report - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

Can volume confirm reversal in Neuphoria Therapeutics Inc.Market Activity Summary & Free High Return Stock Watch Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Neuphoria Therapeutics Inc. stock volume spike explainedJuly 2025 Trends & Target Return Focused Stock Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What candlestick patterns are forming on Neuphoria Therapeutics Inc.Portfolio Value Summary & Stepwise Trade Execution Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 08:17:43 - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Volume spikes in Neuphoria Therapeutics Inc. stock – what they meanJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - newser.com

Sep 29, 2025
pulisher
Sep 27, 2025

What analysts say about Neuphoria Therapeutics Inc stockFlag and Pennant Patterns & Interactive Charts for Smarter Trading - earlytimes.in

Sep 27, 2025
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):